J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India flag India · Delayed Price · Currency is INR
2,412.25
-93.35 (-3.73%)
At close: Jul 16, 2026

BOM:506943 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
7,0956,5965,5264,0983,854
Depreciation & Amortization
1,8171,7021,3771,120722.41
Other Amortization
7.527.976.28-4.19
Loss (Gain) From Sale of Assets
-5.74-2.122.320.4-24.05
Loss (Gain) From Sale of Investments
-251.75-322.08-327.43-69-350.43
Stock-Based Compensation
710.1549.03419.67669.02626.54
Provision & Write-off of Bad Debts
215.1942.91114.0130.71-
Other Operating Activities
-235.39378.84944.43563.2-106.65
Change in Accounts Receivable
-565.8-498-716.04-194.92-2,928
Change in Inventory
-1,544-264.42-720.29-371.67-625.14
Change in Accounts Payable
-202.67834.161,380440.44529.3
Operating Cash Flow
7,0399,0248,0066,2861,701
Operating Cash Flow Growth
-22.00%12.72%27.36%269.50%-45.95%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-831.89-975.88-1,269-724.61-628.7
Sale of Property, Plant & Equipment
18.5611.149.777.7277.75
Sale (Purchase) of Intangibles
--227.19-1,345-6,853-6,439
Investment in Securities
-3,947754.79-1,496-1,8637,002
Other Investing Activities
-1,099-2,52262.07-125.7811.29
Investing Cash Flow
-5,859-2,959-4,038-9,55923.2

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
---6,086-
Total Debt Issued
---6,086-
Short-Term Debt Repaid
-138.04-3,439-125.96-195.25-3.27
Long-Term Debt Repaid
-249.17-131-1,917-956.86-80.38
Total Debt Repaid
-387.21-3,570-2,043-1,152-83.65
Net Debt Issued (Repaid)
-387.21-3,570-2,0434,934-83.65
Issuance of Common Stock
2,320240.03199.9184.83-
Common Dividends Paid
-3,133-2,370-1,570-1,276-1,276
Other Financing Activities
-30.42-96.16-442.13-308.98-24.57
Financing Cash Flow
-1,231-5,797-3,8553,434-1,384

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1.46-0.08-0.160.290.01
Net Cash Flow
-49.09268.76112.81161.96340.7

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
6,2078,0496,7375,5621,073
Free Cash Flow Growth
-22.88%19.46%21.14%418.51%-59.83%
Free Cash Flow Margin
14.96%20.54%19.34%17.66%4.42%
Free Cash Flow Per Share
38.8950.7242.4835.516.93
Levered Free Cash Flow
5,0656,4453,716-2,598-5,711
Unlevered Free Cash Flow
5,0966,5123,988-2,380-5,685

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
30.4296.16442.13308.9824.57
Cash Income Tax Paid
2,5622,0071,325885.941,346
Change in Working Capital
-2,31371.74-56.36-126.16-3,024